Business Context and Reporting Period
This Form 8-K is a current report filed by Neuralstem, Inc. (not Palisade Bio, Inc.) on September 13, 2011. The filing serves as a Regulation FD disclosure regarding a presentation made by company representatives at the Rodman & Renshaw Annual Healthcare Conference in New York, NY.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is informational regarding a corporate event and does not contain financial statement data.
Material Changes
No material financial changes versus a prior period are disclosed in this document. The report solely documents the occurrence of a conference presentation and the issuance of a related press release on September 12, 2011.
Guidance, Outlook, and Risks
The filing references presentation slides (Exhibit 99.01) and a press release (Exhibit 99.02) which may contain management commentary or outlook, but the text of this 8-K does not summarize their content. The document explicitly states that the information is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the correct registrant name is Neuralstem, Inc., not Palisade Bio, Inc.
- Review Exhibit 99.01 (Conference Slides) and Exhibit 99.02 (Press Release) for specific business updates or guidance not detailed in the 8-K text.
- Confirm that no financial metrics are included in this specific filing.